Julian A Abrams
Overview
Explore the profile of Julian A Abrams including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
136
Citations
3421
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Yoon J, Lim F, Shah S, Rubenstein J, Abrams J, Katzka D, et al.
Am J Gastroenterol
. 2024 Jan;
119(7):1289-1297.
PMID: 38275234
Introduction: The incidence of esophagogastric junction adenocarcinoma (EGJAC) has been rising. Intestinal metaplasia of the esophagogastric junction (EGJIM) is a common finding in gastroesophageal reflux (irregular Z-line) and may represent...
12.
Solfisburg Q, Baldini F, Baldwin-Hunter B, Austin G, Lee H, Park H, et al.
Cancer Epidemiol Biomarkers Prev
. 2023 Dec;
33(3):371-380.
PMID: 38117184
Background: Esophageal adenocarcinoma (EAC) is rising in incidence, and established risk factors do not explain this trend. Esophageal microbiome alterations have been associated with Barrett's esophagus (BE) and dysplasia and...
13.
Chandar A, Keerthy K, Gupta R, Grady W, Canto M, Shaheen N, et al.
Am J Gastroenterol
. 2023 Nov;
119(5):823-829.
PMID: 37975600
Introduction: A substantial proportion of patients with esophageal adenocarcinoma (EAC) do not report gastroesophageal reflux disease (GERD) symptoms. This study aimed to compare the risk factor profiles and cancer stage...
14.
Weh K, Howard C, Zhang Y, Tripp B, Clarke J, Howell A, et al.
bioRxiv
. 2023 Sep;
PMID: 37662411
The gut and local esophageal microbiome progressively shift from healthy commensal bacteria to inflammatory-linked pathogenic bacteria in patients with gastroesophageal reflux disease, Barrett's esophagus and esophageal adenocarcinoma (EAC). However, mechanisms...
15.
Natural Language Processing Can Automate Extraction of Barrett's Esophagus Endoscopy Quality Metrics
Soroush A, Diamond C, Zylberberg H, May B, Tatonetti N, Abrams J, et al.
medRxiv
. 2023 Aug;
PMID: 37546941
Objectives: To develop an automated natural language processing (NLP) method for extracting high-fidelity Barrett's Esophagus (BE) endoscopic surveillance and treatment data from the electronic health record (EHR). Methods: Patients who...
16.
Solfisburg Q, Baldini F, Baldwin-Hunter B, Lee H, Park H, Freedberg D, et al.
bioRxiv
. 2023 Jul;
PMID: 37425673
Esophageal adenocarcinoma (EAC) is rising in incidence and associated with poor survival, and established risk factors do not explain this trend. Microbiome alterations have been associated with progression from the...
17.
Shah M, Altorki N, Patel P, Harrison S, Bass A, Abrams J
Nat Rev Clin Oncol
. 2023 Apr;
20(6):390-407.
PMID: 37085570
The care of patients with oesophageal cancer or of individuals who have an elevated risk of oesophageal cancer has changed dramatically. The epidemiology of squamous cell and adenocarcinoma of the...
18.
Crowe B, Krigel A, Li T, Haile R, Al-Ani F, Lebwohl B, et al.
Dis Esophagus
. 2023 Mar;
36(9).
PMID: 36892169
Recent guidelines recommend screening for patients with chronic gastroesophageal reflux disease who have three or more additional risk factors for Barrett's esophagus (BE). Failure to screen high-risk individuals represents a...
19.
Chen Q, Weng K, Lin M, Jiang M, Fang Y, Chung S, et al.
Gastroenterology
. 2023 Feb;
164(7):1119-1136.e12.
PMID: 36740200
Background & Aims: Transformation of stem/progenitor cells has been associated with tumorigenesis in multiple tissues, but stem cells in the stomach have been hard to localize. We therefore aimed to...
20.
Baldwin-Hunter B, Rozenberg F, Annavajhala M, Park H, DiMango E, Keating C, et al.
J Cyst Fibros
. 2023 Jan;
22(4):738-744.
PMID: 36717332
Background: Adults with cystic fibrosis (CF) are at increased risk for colon cancer. CF patients have reductions in intestinal bacteria that produce short chain fatty acids (SCFAs), although it is...